Investigation of oxidative stress and development of lower urinary tract symptoms in the urinary bladder following partial bladder outlet obstruction by proteomic approach

Korean Journal of Urology

Volumn 46, Issue 12, 2005, Pages 1337-1343

  Shim, Jung Hyun ^a   Kim, Hyung Jee ^a  

^a Dankook University College of Medicine   (South Korea)

Author keywords

Bladder outlet obstruction; Oxidative stress; Proteomics

Indexed keywords

BIOLOGICAL MARKER; GALAPTIN; OPTINEURIN; PEROXIREDOXIN; PEROXIREDOXIN 2; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PREPROHAPTOGLOBIN; THIOREDOXIN; TRANSGELIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER NECK STENOSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DETRUSOR MUSCLE; DOWN REGULATION; GENE OVEREXPRESSION; IMAGE ANALYSIS; ISOELECTRIC FOCUSING; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NERVE INJURY; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RAT; RAT STRAIN; SUPERSENSITIVITY; SYMPTOMATOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; URODYNAMICS;

EID: 32944456062     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Caine M. The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy. J Urol 1986;136:1-4
2. Abrams PH, Farrar DJ, Turner-Warwick RT, Whiteside CG, Feneley RC. The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol 1979;121:640-2
3. Barry MJ, Meigs JB. The natural history of benign prostatic hyperplasia. In: Lepor H, editor. Prostatic disease. 2nd ed. Philadelphia: Saunders; 2000;106-15
4. Anderson KE. Storage and voiding symptoms: pathophysiologic aspects. Urology 2003;62(5 Suppl 2):3-10
5. Levin RM, Chichester P, Hass MA, Goslin JA, Buttyan R. Obstructive bladder dysfunction: morphological, biochemical and molecular changes. Eur Urol 2002;1(Suppl):14-20
6. Chapple CR, Smith D. The pathophysiological changes in the bladder obstructed by benign prostatic hyperplasia. Br J Urol 1994;73:117-23
7. Fry CH, Wu C. The cellular basis of bladder instability. Br J Urol 1998;81:1-8
8. Levin RM, Levin SS, Zhao Y, Buttyan R. Cellular and molecular aspects of bladder hypertrophy. Eur Urol 1997;32(Suppl 1):15-21
9. Chen MW, Krasnapolsky L, Levin RM, Buttyan R. An early molecular response induced by acute overdistension of the rabbit urinary bladder. Mol Cell Biochem 1994;132:39-44
10. Flynn BJ, Mian HS, Cera PJ, Kabler RL, Mowad JJ, Cavanaugh AH, et al. Early molecular changes in bladder hypertrophy due to bladder outlet obstruction. Urology 2002;59:978-82
11. Steers WD. Overactive bladder (OAB): What we thought we knew and what we know today. Eur Urol 2002;42(Suppl):3-10
12. Levin RM, Wein AJ, Buttyan R, Monson FC, Longhurst PA. Update on bladder smooth-muscle physiology. World J Urol 1994;12:226-32
13. Levin RM, Brading AF, Mills IW, Longhust PA. Experimental models of bladder obstruction. In: Lepor H, editor. Prostatic disease. 2nd ed. Philadelphia: Saunders; 2000;169-96
14. Katada E, Mitake S, Matsukawa N, Otsuka Y, Tsugu Y, Fujimori O, et al. Distribution of hippocampal cholinergic neurostimulating peptide (HCNP)-like immunoreactivity in organs and tissues of young Wistar rats. Histochem Cell Biol 1996; 105:43-51
15. Katada E, Ojika K, Mitake S, Ueda R. Neuronal distribution and subcellular localization of HCNP-like immunoreactivity in rat small intestine. J Neurocytol 2000;29:199-207
16. Ojika K, Ueki Y, Mitake S, Tsugu Y, Otsuka Y, Katada E. Demonstration of the biological activity of peptide fragments related to human and rat hippocampal cholinergic neurostimulating peptide (HCNP). Neurosci Lett 1996;215:127-30
17. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados M, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002;295:1077-9
18. Shapland C, Hsuan JJ, Totty NP, Lawson D. Purification and properties of transgelin: a transformation and shape change sensitive actin-gelling protein. J Cell Biol 1993;121;1065-73
19. Lawson D, Harrison M, Shapland C. Fibroblast transgelin and smooth muscle SM22 alpha are the same protein, the expression of which is down-regulated in many cell lines. Cell Motil Cytoskeleton 1997;38;250-7
20. Zeidan A, Sward K, Nordstrom I, Ekblad E, Zhang JC, Parmacek MS, et al. Ablation of SM22alpha decreases contractility and actin contents of mouse vascular smooth muscle. FEBS Lett 2004;562:141-6
21. Stefankova P, Kollarova M, Barak I. Thioredoxin - structural and functional complexity. Gen Physiol Biophys 2005;24:3-11
22. Nakamura H. Thioredoxin and its related molecules: update 2005. Antioxid Redox Signal 2005;7:823-8
23. Lim YK, Jenner A, Ali AB, Wang Y, Hsu SI, Chong SM, et al. Haptoglobin reduces renal oxidative DNA and tissue damage during phenylhydrazine-induced hemolysis. Kidney Int 2000;58:1033-44
24. Dietz KJ, Horling F, König J, Baier M. The function of the chloroplast 2-cysteine peroxiredoxin in peroxide detoxification and its regulation. J Exp Bot 2002;53:1321-9
25. Liu FT, Hsu DK, Zuberi RI, Kuwabara I, Chi EY, Henderson WR Jr. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol 1995;147:1016-28
26. Imbe H, Okamoto K, Kadoya T, Horie H, Senba E. Galectin-1 is involved in the potentiation of neuropathic pain in the dorsal horn. Brain Res 2003;993:72-83
27. Kim HJ, Jin JH, Lee GH. The effects of superoxide radical on rat detrusor contractility. Korean J Urol 2000;41:538-42
28. Kim HJ, Park JH, Lee GH, Joo KJ. The harmful effects of superoxide radical and the protective effect of ginseng saponin on rat whole bladder contractility. Korean J Urol 2002;43: 496-501